MXPA05008596A - Metodo para tratar insuficiencia cardiaca cronica y/o niveles elevados de colesterol. - Google Patents

Metodo para tratar insuficiencia cardiaca cronica y/o niveles elevados de colesterol.

Info

Publication number
MXPA05008596A
MXPA05008596A MXPA05008596A MXPA05008596A MXPA05008596A MX PA05008596 A MXPA05008596 A MX PA05008596A MX PA05008596 A MXPA05008596 A MX PA05008596A MX PA05008596 A MXPA05008596 A MX PA05008596A MX PA05008596 A MXPA05008596 A MX PA05008596A
Authority
MX
Mexico
Prior art keywords
acid
tetrayodotiropropionic
administered
patient
triyodotiropropionic
Prior art date
Application number
MXPA05008596A
Other languages
English (en)
Spanish (es)
Inventor
Eugene Morkin
Original Assignee
Univ Arizona
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Arizona filed Critical Univ Arizona
Publication of MXPA05008596A publication Critical patent/MXPA05008596A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
MXPA05008596A 2003-02-18 2003-10-20 Metodo para tratar insuficiencia cardiaca cronica y/o niveles elevados de colesterol. MXPA05008596A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/368,755 US6716877B2 (en) 2001-01-31 2003-02-18 Method to treat chronic heart failure and/or elevated cholesterol levels
PCT/US2003/033333 WO2004073694A1 (en) 2003-02-18 2003-10-20 Method to treat chronic heart failure and/or elevated cholesterol levels

Publications (1)

Publication Number Publication Date
MXPA05008596A true MXPA05008596A (es) 2006-02-28

Family

ID=32907645

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05008596A MXPA05008596A (es) 2003-02-18 2003-10-20 Metodo para tratar insuficiencia cardiaca cronica y/o niveles elevados de colesterol.

Country Status (7)

Country Link
US (1) US6716877B2 (https=)
EP (1) EP1594480A4 (https=)
JP (1) JP2006514665A (https=)
AU (1) AU2003286546B2 (https=)
CA (1) CA2516450A1 (https=)
MX (1) MXPA05008596A (https=)
WO (1) WO2004073694A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI107018B (fi) * 2000-04-06 2001-05-31 Ipsat Therapies Oy Dermatologinen käyttö ja valmiste
US7504435B2 (en) * 2001-01-31 2009-03-17 The Arizona Board Of Regents On Behalf Of The University Of Arizona Method for stimulating weight loss and/or for lowering triglycerides in patients
WO2006128058A2 (en) 2005-05-26 2006-11-30 Metabasis Therapeutics, Inc. Thyromimetics for the treatment of fatty liver diseases
CN1882327A (zh) * 2003-11-19 2006-12-20 症变治疗公司 含磷的新的拟甲状腺素药
WO2006128056A2 (en) * 2005-05-26 2006-11-30 Metabasis Therapeutics, Inc. Novel phosphinic acid-containing thyromimetics
EP2199271A4 (en) * 2007-08-31 2011-05-18 Mitsubishi Gas Chemical Co METHOD FOR PRODUCING PHENOL DERIVATIVES SUBSTITUTED WITH IODINE AT THE ORTHO POSITION
US20090131380A1 (en) * 2007-11-16 2009-05-21 Pekka Heino Novel pharmaceutical composition for topical treatment of skin psoriasis and the treatment method thereof
MX386702B (es) * 2014-02-10 2025-03-19 Fred Hutchinson Cancer Center Tratamiento con halogeno de ataque cardiaco y lesion isquemica.
CA3044059A1 (en) 2016-11-21 2018-05-24 Viking Therapeutics, Inc. Method of treating glycogen storage disease
US11707472B2 (en) 2017-06-05 2023-07-25 Viking Therapeutics, Inc. Compositions for the treatment of fibrosis
US11458094B2 (en) * 2018-01-31 2022-10-04 Regents Of The University Of Minnesota Compositions and methods for treating pulmonary edema or lung inflammation
ES3053674T3 (en) 2018-03-22 2026-01-23 Viking Therapeutics Inc Crystalline forms and methods of producing crystalline forms of a compound
WO2020117962A1 (en) 2018-12-05 2020-06-11 Viking Therapeutics, Inc. Compositions for the treatment of fibrosis and inflammation
CA3177377A1 (en) 2020-03-27 2021-09-30 Regents Of The University Of Minnesota Compositions and methods for treating pulmonary edema or lung inflammation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3109023A (en) 1958-06-10 1963-10-29 Hooker Chemical Corp 2, 3, 6-trichloro-5-nitrobenzoic acid and salts thereof
US5158978A (en) * 1990-02-05 1992-10-27 British Technology Group (U.S.A.) Thyroid hormone treatment of acute cardiovascular compromise
US5284971A (en) 1992-07-16 1994-02-08 Syntex (U.S.A.) Inc. 4-(3-cyclohexyl-4-hydroxy or-methoxy phenylsulfonyl) 3,5 dibromo phenyl acetic thyromimetic cholesterol-lowering agents
US6221911B1 (en) * 1995-06-07 2001-04-24 Karo Bio Ab Uses for thyroid hormone compounds or thyroid hormone-like compounds
US5883294A (en) 1997-06-18 1999-03-16 The Regeants Of The University Of California Selective thyroid hormone analogs
US6534676B2 (en) * 2001-01-31 2003-03-18 The Arizona Board Of Regents On Behalf Of The University Of Arizona Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same

Also Published As

Publication number Publication date
WO2004073694A1 (en) 2004-09-02
EP1594480A1 (en) 2005-11-16
US6716877B2 (en) 2004-04-06
CA2516450A1 (en) 2004-09-02
EP1594480A4 (en) 2007-08-29
JP2006514665A (ja) 2006-05-11
AU2003286546A1 (en) 2004-09-09
US20030147815A1 (en) 2003-08-07
AU2003286546B2 (en) 2009-06-11

Similar Documents

Publication Publication Date Title
US6534676B2 (en) Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same
KR100952786B1 (ko) 제약 조성물
AU2002243801A1 (en) Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same
AU2003286546B2 (en) Method to treat chronic heart failure and/or elevated cholesterol levels
TW201216958A (en) Synthetic triterpenoids and methods of use in the treatment of disease
JP2001515864A (ja) 非天然ｆｐ選択的作用薬を使用した骨体積増加方法
Suh et al. Pharmacokinetic and local tissue disposition studies of naproxen following topical and systemic administration in dogs and rats
JP2013515020A (ja) 溶媒混合物およびビタミンｄ誘導体から成る医薬品組成物または類似体
JP2540294B2 (ja) 経皮吸収製剤
Ghanem A review on recent advances in transdermal drug delivery systems of tamsulosin
EA007351B1 (ru) Фармацевтическая композиция для чрескожной доставки физиологически активных агентов
US20050159490A1 (en) Method to treat chronic heart failure and/or elevated cholesterol levels
AU2001287706B2 (en) Treatment of burns
US20050266060A1 (en) Transdermal delivery system for treatment of cognitive disorders
BE1018506A3 (nl) Samenstelling van een hydrocortisone, zijn derivaten, metabolieten, prodrugs of mengsels daarvan houdende liposomale gel en het gebruik ervan.
JPS59216818A (ja) 経皮吸収外用製剤
CN1415296A (zh) 含有川芎嗪的组合物以及川芎嗪透皮贴剂及其制备方法
JP2001515863A (ja) 骨体積増加方法
AU2001287706A1 (en) Treatment of burns
EE202200014A (et) Meditsiiniline plaaster
JPH0611716B2 (ja) 経皮吸収促進剤
CN114469878A (zh) 一种普罗布考干乳剂组合物及其制备方法和应用
JPH06247846A (ja) 塩酸リトドリンの経皮吸収製剤用組成物
IE83245B1 (en) Treatment of burns
JP2000351729A (ja) トロンボキサンａ２受容体拮抗剤の経皮吸収製剤

Legal Events

Date Code Title Description
FG Grant or registration